Press release —
NNIT recognized as Major Contender in global Pharmaceutical R&D IT Services assessment 2026
NNIT has been positioned as a Major Contender in Everest Group’s global Pharmaceutical R&D IT Services PEAK Matrix® assessment 2026, recognizing the company’s capabilities and market position in a pharmaceutical R&D landscape that is becoming increasingly digital, data-driven, and AI-enabled.
The assessment places NNIT alongside major global consulting and technology companies as well as specialized R&D providers supporting the digital transformation of pharmaceutical R&D.
“This recognition supports our strategic ambition to become the innovative, AI-driven niche specialist in Life Sciences. It validates the strong position we have built in selected areas where we aim to be deeper and better than our immediate competitors – and it points to more opportunities ahead,” says Claus Rydkjær, CEO, NNIT.
Focused expertise in a complex R&D landscape
Pharmaceutical R&D is under pressure to become more efficient, connected, and technology-enabled, while continuing to meet strict regulatory requirements. For companies operating in this environment, digital transformation requires both technology expertise and a deep understanding of regulated Life Sciences processes.
NNIT supports pharmaceutical and biotech companies in modernizing their R&D landscapes and strengthening technology-enabled operations. The company’s capabilities span Clinical, Regulatory Affairs, and Drug Safety, supported by expertise in migration, data, and AI.
The recognition reflects NNIT’s strategic focus on selected areas of Life Sciences where the company combines technology capabilities with domain knowledge and experience from highly regulated customer environments.
What the Major Contender recognition means
Everest Group is a global research and advisory firm known for its independent assessments of technology and services providers. Its PEAK Matrix® is a proprietary evaluation framework used to assess providers based on market impact and overall capability, including factors such as client base, growth, scale of operations, scope of services, technology and innovation, delivery footprint, and buyer feedback.
Being positioned as a Major Contender indicates that NNIT has demonstrated relevant capabilities and market presence within Pharmaceutical R&D IT Services. In the PEAK Matrix® framework, providers are typically categorized as Leaders, Major Contenders, or Aspirants, based on their relative performance in the assessed market.
Disclaimer
Licensed extracts taken from Everest Group’s PEAK Matrix® Reports may be used by licensed third parties for use in their own marketing and promotional activities and collateral. Selected extracts from Everest Group’s PEAK Matrix® reports do not necessarily provide the full context of our research and analysis. All research and analysis conducted by Everest Group’s analysts and included in Everest Group’s PEAK Matrix® reports is independent and no organization has paid a fee to be featured or to influence their ranking. To access the complete research and to learn more about our methodology, please visit Everest Group PEAK Matrix® Reports.
Topics
Categories
NNIT is a leading provider of IT solutions to life sciences internationally, and to the public and private sectors in Denmark.
We focus on high complexity industries and thrive in environments where regulatory demands and complexity are high. We advise on and build sustainable digital solutions that work for the patients, citizens, employees, end users and customers.
We strive to build unmatched excellence in the industries we serve, and we use our domain expertise to represent a business first approach – strongly supported by a selection of partner technologies, but always driven by business needs rather than technology.
NNIT consists of group company NNIT A/S and subsidiaries, including SCALES. Together, these companies employ around 1,500 people in Europe, Asia and USA.
Learn more at www.nnit.com.
